The standard BPC-157 dosage is 250-500 mcg injected subcutaneously once or twice daily for 4-8 weeks, adjusted for injury type, body weight, and reconstitution concentration
Access to quality care is our number one priority
Cultivating a positive and resilient mindset can enhance your ability to cope with challenges and setbacks, enabling you to stay committed to your wellness objectives
Unlike many other research peptides that require acidic solvents or DMSO, its water-solubility simplifies laboratory handling
BPC-157 is prohibited by WADA and should not be used by athletes subject to drug testing
Per CMS NCCI Policy Manual Chapter 6 effective January 1, 2026, a distinct procedural service requires distinct clinical documentation, and the CMS NCCI Policy Manual Chapter 6 January 2026 is the authoritative source for colonoscopy endoscopy family bundling rules